Skip Navigation



ToxSci Advance Access published online on May 24, 2004

Toxicological Sciences, doi:10.1093/toxsci/kfh175
Toxicological Sciences © Society of Toxicology 2004; all rights reserved
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
81/1/26    most recent
kfh175v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Curtin, G. M.
Right arrow Articles by Mosberg, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtin, G. M.
Right arrow Articles by Mosberg, A. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received March 17, 2004
Accepted May 7, 2004

Carcinogenicity

Lung Tumorigenicity in A/J and rasH2 Tg Mice Following Mainstream Tobacco Smoke Inhalation

Geoffrey M. Curtin 1*, Mark A. Higuchi 1, Paul H. Ayres 1, James E. Swauger 1, Arnold T. Mosberg 1

1 Research and Development, R.J. Reynolds Tobacco Co., Winston-Salem, North Carolina, 27102

* To whom correspondence should be addressed. E-mail: curting{at}rjrt.com.


   Abstract

Hypothesizing that their respective genetic backgrounds would confer an increased sensitivity to lung tumorigenesis, the plausibility of selected rodent models for the inhalation testing of mainstream tobacco smoke (MTS) was evaluated. Strain A/J and rasH2 transgenic (Tg) mice were exposed to MTS from Kentucky 1R4F research cigarettes using either a whole-body or nose-only exposure regimen. The whole-body regimen included a 20-week exposure period [0.200 mg wet total particulate matter/liter (WTPM/L), 6 hrs/d, 5 d/wk], while nose-only dosing proceeded for 28 weeks [0.040, 0.125 or 0.400 mg WTPM/L, 3 hrs/d, 5 d/wk]; both regimens included a 16-week recovery period. Gross and microscopic examinations of the lungs were used to evaluate tumor formation, with experimental results supporting the following conclusions: 1) evaluation of MTS-induced tumorigenicity based on gross evaluation versus microscopic confirmation provides strikingly disparate results, indicating that serial sectioning is necessary for a definitive assessment of lung tumors; 2) while the dosing regimens employed do not allow for a definitive comparison, whole-body exposure appeared to be more effective for inducing statistical changes in tumor multiplicity and incidence compared to nose-only exposure; 3) exposure-related stress, evidenced as reductions in both body weight gain and background tumor formation, represents a potential confounder during inhalation testing of MTS tumorigenicity, with additional investigation warranted in order to validate the specificity of exposure-related responses; and 4) comparative findings between A/J and rasH2 Tg mice suggest that the former may be overly sensitive to exposure-related stress, potentially influencing tumorigenic responses.

Key Words: mainstream tobacco smoke, mouse lung tumorigenicity, strain A/J, rasH2 transgenic .


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
R. Balansky, G. Ganchev, M. Iltcheva, V. E. Steele, F. D'Agostini, and S. De Flora
Potent carcinogenicity of cigarette smoke in mice exposed early in life
Carcinogenesis, October 1, 2007; 28(10): 2236 - 2243.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. A. Hutt, B. R. Vuillemenot, E. B. Barr, M. J. Grimes, F. F. Hahn, C. H. Hobbs, T. H. March, A. P. Gigliotti, S. K. Seilkop, G. L. Finch, et al.
Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways
Carcinogenesis, November 1, 2005; 26(11): 1999 - 2009.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.